While BPC 157 may support recovery, it is not specifically designed for hangover relief
"Safety and efficacy of the dual glucagon-like peptide-1/glucagon receptor agonist survodutide in people with overweight or obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial." The Lancet (2023)
There is an increasing focus on the potential contributory mechanistic role of the gut microbiota in the metabolic effects of glucoregulatory and weight loss promoting drugs, including glucagon-like peptide-1 (GLP-1) receptor agonists, which have become well-established therapies in type 2 diabetes and obesity 16,17
Diarrhea, constipation, and vomiting occur in varying degrees among patients
Dihexa Side Effects & Safety There is limited clinical data available on the side effects of Dihexa, as it is still under research and not widely used in clinical settings